ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Role of gut microbiota-derived branched-chain amino acids in the pathogenesis of Parkinson?s disease: An animal study

Yan, Zhenzhen; Yang, Fan; Sun, Linlin; Yu, Jing; Sun, Lina; Si, Yao; Yao, Lifen*哈尔滨医科大学; 1
Brain, Behavior, and Immunity2022-11DOI: 10.1016/j.bbi.2022.09.009
18被引5阅读
引用收藏
分享

摘要

Neuroinflammation caused by the disorder of gut microbiota and its metabolites is associated with the patho-genesis of Parkinson's disease (PD). Thus, it is necessary to identify certain molecules derived from gut micro-biota to verify whether they could become intervention targets for the treatment of PD. The branched-chain amino acids (BCAAs), as a common dietary supplement, could modulate brain function. Herein, we investigated the longitudinal shifts of microbial community in mice treated with rotenone for 0, 3 and 4 weeks by 16S rRNA gene sequencing to identify the microbial markers at different PD stages. Serum BCAAs were determined by gas chromatography-mass spectrometry. Then, rotenone-induced mice were given a high BCAA diet to evaluate the motor and non-motor functions, dopaminergic neuron loss, and inflammation levels. Using a PD mouse model, we discovered that during PD progression, the alterations of gut microbiota compositions led to the peripheral decrease of BCAAs. Based on the serum lipopolysaccharide binding protein concentrations and the levels of pro-inflammatory factors (including tumor necrosis factor-alpha, interleukin [IL]-1 beta, and IL-6) in the colon and substantia nigra, we found that the high BCAA diet could attenuate the inflammatory levels in PD mice, and reverse motor and non-motor dysfunctions and dopaminergic neuron impairment. Together, our results emphasize the dynamic changes of gut microbiota and BCAA metabolism and propose a novel strategy for PD therapy: a high BCAA diet intervention could improve PD progression by regulating the levels of inflammation.

学科与关键词

关键词
Parkinson?s diseaseMicrobiota-gut-brain axisBiomarkersMetabolomicsBranched-chain amino acids
相关
加载中…
  • Role of the gut-microbiota-metabolite axis in the rotenone model of early-stage Parkinson's Disease
    Yan, Zhenzhen; Li, Ruihua; Shi, Wanying; Yao, Lifen*Metabolic Brain Disease, 2022, 37(7): 2511-2520.被引 3
  • Metabolomic analysis of serum short-chain fatty acid concentrations in a mouse of MPTP-induced Parkinson's disease after dietary supplementation with branched-chain amino acids
    Mi, Na; Ma, Lili; Li, Xueying; Fu, Jia; Bu, Xinxin; Liu, Fei; Yang, Fan; Zhang, Yali*; Yao, Lifen*OPEN MEDICINE, 2023, 18(1): 20230849.
  • The role of gut dysbiosis in Parkinson's disease: mechanistic insights and therapeutic options
    Wang, Qing*; Luo, Yuqi; Chaudhuri, K. Ray; Reynolds, Richard; Tan, Eng-King*; Pettersson, Sven*Brain; a journal of neurology, 2021, 144: 2571-2593.被引 98
查看全部 →

发表信息

论文状态
公开发表
期刊
Brain, Behavior, and Immunity
发表日期
2022-11
卷期
第 106 卷
页码
307-321
DOI
10.1016/j.bbi.2022.09.009
语言
ENGLISH
期刊等级
1区
成果收录
SCIE
资助标注
National Natural Science Foundation of China; China Postdoctoral Science Foundation; Research and Innovation Fund of the First Affiliated Hospital of Harbin Medical Uni-versity; Fundamental Research Fund for Heilongjiang Universities; [62072143]; [81271208]; [2021M693825]; [2021B17]; [2022-KYYWF]

作者

  • Y

    Yan, Zhenzhen (第一作者)

    1 · harbin med univ

  • Y

    Yang, Fan

    1 · harbin med univ

查看全部 7 位作者收起作者
  • S

    Sun, Linlin

  • Y

    Yu, Jing

    1 · harbin med univ

  • S

    Sun, Lina

  • S

    Si, Yao

    1 · harbin med univ

  • Y

    Yao, Lifen (通讯)

    1 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417